CB Therapeutics

05/09/2024

Excited to announce the sustainable production of Retinol and its derivatives using precision fermentation.
#

Carlsbad, California--(Newsfile Corp. - May 9, 2024) - CB Therapeutics, a premier biotechnology firm specializing in precision fermentation, proudly unveils...

05/02/2024

We are excited about the news for reclassification of cannabinoids to Schedule 3 by the DEA. This will enable researchers and pharmaceutical companies to conduct clinical trials and create life changing therapeutics for hundreds of millions around the globe.

Our patented biosynthesis processes will enable companies to deploy these therapeutics with clean, eco-friendly, and sustainable products.

Carlsbad, California--(Newsfile Corp. - May 2, 2024) - CB Therapeutics, a leading biotechnology firm specializing in precision fermentation, announces groundbreaking advancements in the production of pharmaceutical-grade cannabinoids and their analogs. With the recent reclassification of cannabinoid...

04/19/2024

Psychedelics are creating novel therapeutics for the treatment of difficult mental health issues. Here is an article from SynBioBeta, the leading synthetic biology organization, on the impact of psychedelics made using precision fermentation. We are proud of our team to enable us as being the leader In this space, and always looking for collaborations that will allow a quicker rollout of these breakthrough treatments.

Precision fermentation allows companies to produce a range of psychedelics and derivatives at scale

04/17/2024

The natural dyes, colors, and antioxidants market is booming across the globe. CB Therapeutics has developed these molecules using sustainable, eco-friendly, and low carbon emissions precision fermentation processes.

CB Therapeutics (the “Company”), a frontrunner in biotechnology and precision fermentation, announces a monumental stride towards sustainability with

02/10/2023

A Better Way to Feed Our Future

Our cellular agriculture platform is capable of generating a large range of products and ingredients, already having developed prototypes for animal-free proteins, fats, vitamins, colorants, flavors, aromas, and more. In recent years, precision fermentation has been used to produce a range of ingredients that could previously only be obtained from animal sources. These include proteins such as casein, collagen, gelatin, and pepsin — which have potential applications across a range of industries — along with food ingredients such as egg protein and beef fat.



https://vimeo.com/795042219

This is "Food Tech_Environment_Social Media Clip_16X9.mp4" by Stephanie Elliott on Vimeo, the home for high quality videos and the people who love them.

02/09/2023

Sustainably creating molecules within the Psychedelic, Cannabis and Food Technology industry, CB Therapeutics launched its crowdfunding campaign which allows members of the public to purchase an equity stake in the company – something that’s usually only available and accessed for accredited investors and VCs.

CB Therapeutics is advancing biotechnology to solve some of the most challenging problems facing humanity today.

02/08/2023

Mental health disorders have become the leading health problem in the world, affecting over 1 Billion people across the globe. A startling increase in depression, addiction, PTSD, anxiety and other treatable diseases now afflict over one in five people.

By 2027, the psychedelic potential global market is projected to reach $11B. Modern science has been slow in finding new treatments to allow patients to live happier, healthier, and more productive lives.

There is a demanding need to provide alternatives to conventional pharmaceutical drugs, to find trusted and ethical medicines to serve our mental health community.

That’s why we are very proud to be at the forefront of the psychedelic therapeutic movement. We are a leader in a growing number of companies and organizations innovating in the psychedelic medicine space to unlock these powerful molecules.

The potential for this market and its life-changing capabilities is only at the beginning.



https://vimeo.com/795042857

This is "Psychedelics_social clip.mp4" by Stephanie Elliott on Vimeo, the home for high quality videos and the people who love them.

02/07/2023

CB Therapeutics provides a reliable source of Muscimol and other rare high value compounds! Please contact us to find out more: tiffany@cbthera.com

02/07/2023

Sustainably creating molecules within the Psychedelic, Cannabis and Food Technology industry, CB Therapeutics launched its crowdfunding campaign which allows members of the public to purchase an equity stake in the company – something that’s usually only available and accessed for accredited investors and VCs.

CB Therapeutics is advancing biotechnology to solve some of the most challenging problems facing humanity today.

Now, it’s opened a fundraising opportunity with a much lower barrier to entry. You can now invest and purchase equity for as low as: $100.

Link to learn more is below!

https://lnkd.in/gq47uDmU

CB Therapeutics, Inc. – Advanced synthetic biology for planet and human health – is now accepting investments on Republic.

02/06/2023

Sustainably creating molecules within the Psychedelic, Cannabis and Food Technology industry, CB Therapeutics launched its equity crowdfunding campaign which allows members of the public to purchase an equity stake in the company – something that’s usually only available and accessed for accredited investors and VCs.

CB Therapeutics is advancing biotechnology to solve some of the most challenging problems facing humanity today.

This is YOUR opportunity to back and own a stake in one of the leading companies in the world that creates food and medicine products sustainably! You can now invest and purchase equity for as low as: $100.

Link to learn more and view our video is below!

https://lnkd.in/gq47uDmU

CB Therapeutics, Inc. – Advanced synthetic biology for planet and human health – is now accepting investments on Republic.

12/20/2021

Two esteemed doctors join CBTherapeutics
in its exploration of innovative approaches to the production of novel psychedelics and cannabinoids so researchers can address the unmet needs of patient communities.

Read the full press release —>

SAN DIEGO, Dec. 20, 2021 (GLOBE NEWSWIRE) -- CB Therapeutics today announces the appointments of Dr. Stephen Wright and Dr. Brian Barnett to its newly formed Medical Advisory Board. Dr. Wright has more than 30 years of experience in medicines development, having worked on both sides of the Atlantic....

11/27/2021

10/21/2021